Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neki V Patel

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
SLAS Discovery : Advancing Life Sciences R & D|March 16, 2017
Microfluidic Mobility Shift Assay for Real-Time Analysis of Peptide N-PalmitoylationThomas Lanyon-Hogg, Neki V Patel, Markus Ritzefeld, et al.
ACS Medicinal Chemistry Letters|November 25, 2016
Design and Synthesis of Tesirine, a Clinical Antibody-Drug Conjugate Pyrrolobenzodiazepine Dimer PayloadArnaud C Tiberghien, Jean-Noel Levy, Luke A Masterson, et al.
Bioorganic & Medicinal Chemistry Letters|February 12, 2017
Synthesis and in vitro evaluation of SG3227, a pyrrolobenzodiazepine dimer antibody-drug conjugate payload based on sibiromycinGary C Kemp, Arnaud C Tiberghien, Neki V Patel, et al.
European Journal of Medicinal Chemistry|July 7, 2019
Synthesis and evaluation of pyrrolobenzodiazepine dimer antibody-drug conjugates with dual β-glucuronide and dipeptide triggersStephen J Gregson, Allison M Barrett, Neki V Patel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 15, 2025
Derivation of AZD5335, a Novel FRα-Targeted TOP1i-Loaded ADC, for the Treatment of FRα-Expressing CancersJason J Zoeller, Ravinder Tammali, Roger B Dodd, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
SLAS Discovery : Advancing Life Sciences R & D|March 16, 2017
Microfluidic Mobility Shift Assay for Real-Time Analysis of Peptide N-PalmitoylationThomas Lanyon-Hogg, Neki V Patel, Markus Ritzefeld, et al.
ACS Medicinal Chemistry Letters|November 25, 2016
Design and Synthesis of Tesirine, a Clinical Antibody-Drug Conjugate Pyrrolobenzodiazepine Dimer PayloadArnaud C Tiberghien, Jean-Noel Levy, Luke A Masterson, et al.
Bioorganic & Medicinal Chemistry Letters|February 12, 2017
Synthesis and in vitro evaluation of SG3227, a pyrrolobenzodiazepine dimer antibody-drug conjugate payload based on sibiromycinGary C Kemp, Arnaud C Tiberghien, Neki V Patel, et al.
European Journal of Medicinal Chemistry|July 7, 2019
Synthesis and evaluation of pyrrolobenzodiazepine dimer antibody-drug conjugates with dual β-glucuronide and dipeptide triggersStephen J Gregson, Allison M Barrett, Neki V Patel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 15, 2025
Derivation of AZD5335, a Novel FRα-Targeted TOP1i-Loaded ADC, for the Treatment of FRα-Expressing CancersJason J Zoeller, Ravinder Tammali, Roger B Dodd, et al.
Pageof 1